Molecular prognostic markers in pancreatic cancer: a systematic review.
about
Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patientsPancreatic cancer: pathogenesis, prevention and treatmentSMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.Cyclin D as a therapeutic target in cancerIdentification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancerImmunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis.Pancreatic cancer serum detection using a lectin/glyco-antibody array methodComparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder.Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues.Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.Tailoring to RB: tumour suppressor status and therapeutic response.DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinomaGoogle goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes.Gene therapy in pancreatic cancer.Serum HSP70: a novel biomarker for early detection of pancreatic cancer.The molecular targets for the diagnosis and treatment of pancreatic cancer.Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma.Elevated DNA damage response in pancreatic cancer.KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor.Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival.Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer.The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line.Binding of pro-prion to filamin A: by design or an unfortunate blunderInhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinoma.Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer.Consequence of the tumor-associated conversion to cyclin D1bA single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer.Prognosis Relevance of Serum Cytokines in Pancreatic Cancer.Current knowledge on pancreatic cancer.Neoadjuvant chemoradiation in patients with pancreatic adenocarcinoma.Evolution of cellular morpho-phenotypes in cancer metastasis.Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors.Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancerMolecular mechanisms of pancreatic cancer and potential targets of treatment.Biodistribution and pharmacokinetics of EGFR-targeted thiolated gelatin nanoparticles following systemic administration in pancreatic tumor-bearing mice.Microarray technologies for gene transcript analysis in pancreatic cancer.Pancreatic carcinogenesisTW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer.
P2860
Q21260399-FC6376F2-A6B5-4EBE-A3C4-05784E8C7157Q24670990-04DBB6BA-2C48-4DE9-AAD5-C052BC87B318Q27851475-56EC13A8-C5A7-4D50-BE2F-F452477300F7Q27851677-7C5ECD2C-8A29-4E8F-B9F1-5B6BE390E92CQ28242623-7C736CE7-6C64-4796-9A11-C73DB80DC601Q28473944-077A9AF1-7DD4-4CB5-B496-0ECEE8ABA6FEQ30481528-3F37B067-CA87-4007-96B5-0087431B16C4Q33391974-50C7EAD5-FF4E-42CF-BD2E-AA21D097D1D2Q33572690-8378ADE6-A0EA-4655-9081-E41890219DBAQ33693132-84031E23-0366-453C-AAB2-D1D3E9A8DD7CQ33960755-6FC3F136-EFF0-4708-BE7E-106F53B9359FQ34040108-2345E6A2-9321-4422-BB5B-607FAB1E9270Q34171014-6F97A0D4-EA4A-4014-93B0-E80835ECE068Q34276961-E8AE7088-6E6B-4CF4-8F05-E40BEF516117Q34302954-8A88014F-2DBC-4E08-A206-27ADEA90CC7BQ34322212-B9321211-E997-4B51-86A6-183680349966Q34494019-75B10242-BA18-4155-9F8E-1644237ABB42Q34506739-C3F79E94-7D42-4946-A7C3-5C3BAFE949FCQ34566631-5CF61671-A4E4-466E-B536-B4B045D15055Q34967352-CDA23B01-C6B0-4057-BD63-88950EFC3659Q34988674-B66D90E4-D494-4C46-94D1-2EE3F0FA7DB0Q35017119-2C1FD391-CD3E-437D-9B4B-AC059697F474Q35089751-41C94B18-14AB-4B28-B439-E62C25FA5041Q35173852-B8ABFD09-CF84-4E07-914F-D9815FEAD72CQ35369888-5A8EFB92-9A20-413E-8CC2-68E9B2C8A7C9Q35552067-00081639-0C7C-4221-B70A-8F457CEE5875Q35680802-8CA45AE7-A072-4EEC-889C-9DD0CB2818BFQ35822584-755F9B7C-ABD7-48F3-B5D5-30E12C33BB37Q35911669-FD5EBC85-7B76-45DD-B40F-2488FC2C52A8Q35963911-9330CB77-DC51-4B2C-9048-ACAB8681C6EBQ35971808-26554268-54E9-43F0-8626-2A2C1F89A0D9Q36253159-0DC25E7E-301F-4BE7-8FA3-009C4EE12AB7Q36379336-B55E53A8-D133-478B-9F3A-A8C440E86B2FQ36405930-6EA7B5D7-7A9D-4B9D-BF35-E98E7B02804EQ36645390-0E772CB7-845B-4E34-93C8-52EED9302143Q36758436-46D3645C-EA2C-41AE-A6F1-82A413D81C9BQ36836865-53D2C1E1-AEA7-48C1-B8CA-0599FDC38AC9Q37058428-41E20999-120F-4ADA-931A-D707D0ADE51CQ37125627-FE582BAC-77C1-4314-B9D2-3BD1F8F62143Q37154117-16DC8E3F-7B08-4AB4-BA53-0F751F782AA6
P2860
Molecular prognostic markers in pancreatic cancer: a systematic review.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Molecular prognostic markers in pancreatic cancer: a systematic review.
@ast
Molecular prognostic markers in pancreatic cancer: a systematic review.
@en
Molecular prognostic markers in pancreatic cancer: a systematic review.
@nl
type
label
Molecular prognostic markers in pancreatic cancer: a systematic review.
@ast
Molecular prognostic markers in pancreatic cancer: a systematic review.
@en
Molecular prognostic markers in pancreatic cancer: a systematic review.
@nl
prefLabel
Molecular prognostic markers in pancreatic cancer: a systematic review.
@ast
Molecular prognostic markers in pancreatic cancer: a systematic review.
@en
Molecular prognostic markers in pancreatic cancer: a systematic review.
@nl
P2093
P1476
Molecular prognostic markers in pancreatic cancer: a systematic review.
@en
P2093
P304
P356
10.1016/J.EJCA.2005.04.044
P577
2005-09-16T00:00:00Z